These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 12143470)

  • 21. Sodium balance in maintenance hemodialysis.
    Santos SF; Peixoto AJ
    Semin Dial; 2010; 23(6):549-55. PubMed ID: 21175831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of low sodium dialysate in chronic hemodialysis patients: an echocardiographic study.
    Sayarlioglu H; Erkoc R; Tuncer M; Soyoral Y; Esen R; Gumrukcuoglu HA; Dogan E; Sayarlioglu M
    Ren Fail; 2007; 29(2):143-6. PubMed ID: 17365927
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thirst in patients on chronic hemodialysis: What do we know so far?
    Bossola M; Calvani R; Marzetti E; Picca A; Antocicco E
    Int Urol Nephrol; 2020 Apr; 52(4):697-711. PubMed ID: 32100204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patterns of interdialytic weight gain during the first year of hemodialysis.
    Welch JL; Perkins SM; Johnson CS; Kraus MA
    Nephrol Nurs J; 2006; 33(5):493-9. PubMed ID: 17044434
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of dialytic modalities on clinical outcomes in ESRD patients with familial Mediterranean fever.
    Sahin S; Sahin GM; Ergin H; Kantarci G
    Ren Fail; 2007; 29(3):315-9. PubMed ID: 17497446
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between interdialytic weight gain and nutritional markers in younger and older hemodialysis patients.
    Yang SC; Chiang CK; Hsu SP; Hung KY
    J Ren Nutr; 2008 Mar; 18(2):210-22. PubMed ID: 18267214
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of captopril-bound Fe by end-stage renal failure patients during hemodialysis.
    Averbukh Z; Berman S; Kishinevsky E; Feldman L; Cohn M; Rapoport M; Galperin E; Dishi V; Weissgarten J
    J Nephrol; 2004; 17(1):101-6. PubMed ID: 15151265
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sodium gradient: a tool to individualize dialysate sodium prescription in chronic hemodialysis patients?
    Penne EL; Sergeyeva O
    Blood Purif; 2011; 31(1-3):86-91. PubMed ID: 21228573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thirst distress and interdialytic weight gain: how do they relate?
    Jacob S; Locking-Cusolito H
    CANNT J; 2004; 14(3):33-7. PubMed ID: 15537039
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of increasing dialysis dose in overweight hemodialysis patients on quality of life: a 6-week randomized crossover trial.
    Wang W; Tonelli M; Hemmelgarn B; Gao S; Johnson JA; Taub K; Manns B;
    Am J Kidney Dis; 2008 May; 51(5):796-803. PubMed ID: 18436090
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interdialytic weight gain and dry weight.
    Levin NW; Zhu F; Keen M
    Blood Purif; 2001; 19(2):217-21. PubMed ID: 11150813
    [No Abstract]   [Full Text] [Related]  

  • 32. Interdialytic weight gain in patients on hemodialysis is associated with dry mouth and thirst.
    Bots CP; Brand HS; Veerman EC; Valentijn-Benz M; Van Amerongen BM; Valentijn RM; Vos PF; Bijlsma JA; Bezemer PD; Ter Wee PM; Amerongen AV
    Kidney Int; 2004 Oct; 66(4):1662-8. PubMed ID: 15458464
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fluid dynamics during hemodialysis in relationship to sodium gradient between dialysate and plasma.
    Sarkar SR; Wystrychowski G; Zhu F; Usvyat LA; Kotanko P; Levin NW
    ASAIO J; 2007; 53(3):339-42. PubMed ID: 17515726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Control of arterial hypertension by means of a regimen of hemodialysis on alternate days (HDAA or EODD: "Every Other Day Dialysis") versus 2 conventional regiments of 4 and 5 hours per session 3 times a week with 72 hours without sessions during the weekends].
    Lozano A; Benavides B; Quirós P; Jiménez-Moreno J; Figueroa E; Fernández-Marchena D; García-Pérez MA; Fernández-Ruiz E
    Nefrologia; 2006; 26(6):695-702. PubMed ID: 17227247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of the thirst distress scale.
    Welch JL
    Nephrol Nurs J; 2002 Aug; 29(4):337-41; discussion 343. PubMed ID: 12224366
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of cilazapril on hyperdipsia in hemodialyzed patients.
    Kuriyama S; Tomonari H; Sakai O
    Blood Purif; 1996; 14(1):35-41. PubMed ID: 8718563
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Review of dialysate calcium concentration in hemodialysis.
    Toussaint N; Cooney P; Kerr PG
    Hemodial Int; 2006 Oct; 10(4):326-37. PubMed ID: 17014507
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dialysate Sodium: Choosing the Optimal Hemodialysis Bath.
    Munoz Mendoza J; Arramreddy R; Schiller B
    Am J Kidney Dis; 2015 Oct; 66(4):710-20. PubMed ID: 25987259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ACE inhibitors or angiotensin II receptor blockers in dialysed patients and erythropoietin resistance.
    Saudan P; Halabi G; Perneger T; Wasserfallen JB; Wauters JP; Martin PY;
    J Nephrol; 2006; 19(1):91-6. PubMed ID: 16523432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modifiable variables affecting interdialytic weight gain include dialysis time, frequency, and dialysate sodium.
    Thomson BK; Dixon SN; Huang SH; Leitch RE; Suri RS; Chan CT; Lindsay RM
    Hemodial Int; 2013 Oct; 17(4):576-85. PubMed ID: 23782770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.